Gaudium IVF & Women Health IPO
Gaudium IVF & Women Health IPO is priced at ₹75–₹79 per share with an issue size of ₹165 crore. The IPO opens on Feb 20, 2026 and closes on Feb 24, 2026, with a lot size of 189 shares and a minimum investment of ₹14,931.
Gaudium IVF & Women Health Limited IPO
- IPO Dates
- Feb 20, 2026 – Feb 24, 2026
- Price band
- ₹75-79 per equity share
- Minimum Investment
- ₹14,931
- Issue size
- ₹165 Cr
- Lot size
- 189
- Allotment Date
- Feb 25, 2026
- Listing
- Feb 27, 2026
- Listing At
- BSE, NSE
IPO timeline
-
Feb 20, 2026
Open Date
Completed
-
Feb 24, 2026
Close Date
Completed
-
Feb 25, 2026
Allotment Date
Completed
-
Feb 27, 2026
Listing Date
Completed
Gaudium IVF & Women Health IPO Expected Premium (Grey Market Trend)
Gaudium IVF & Women Health IPO GMP today is ₹8. Grey market premium (GMP) indicates expected listing sentiment.
Gaudium IVF & Women Health IPO expected premium (also known as grey market premium or GMP) indicates current market sentiment and potential listing expectations.
Expected Premium provided in this website is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Gaudium IVF & Women Health IPO Live Subscription Details
View Subscription DetailsGaudium IVF & Women Health IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Gaudium IVF & Women Health IPO Essentials
Gaudium IVF & Women Health IPO Details
Gaudium IVF & Women Health IPO is priced at ₹75-79 per share with a total issue size of 165 crore. The IPO has a lot size of 189 shares and will be listed on BSE and NSE.
- Issue price
- ₹75-79 per equity share
- Lot size
- 189 shares
- Face value
- ₹5 Per Equity Share
- Issue size
- ₹165 Crores : 90 Crores Fresh + 75 Crores OFS
- Total issue size
- 2,08,86,200 shares
(aggregating up to ₹165 crore) - Fresh issue
- 1,13,92,500 shares
(aggregating up to ₹90 crore) - Offer for sale (OFS)
- 94,93,700 shares
(aggregating up to ₹75 crore) - Listing at
- BSE, NSE
- Listing date
- Registrar
- Bigshare Services Pvt.Ltd.
- Lead manager
-
Sarthi Capital Advisors Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 189 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 189 | ₹14,931 |
| Retail(max) | 13 | 2,457 | ₹1,94,103 |
| sHNI(min) | 14 | 2,646 | ₹2,09,034 |
| sHNI(max) | 66 | 12,474 | ₹9,85,446 |
| sHNI(min) | 67 | 12,663 | ₹10,00,377 |
Gaudium IVF & Women Health IPO Reservation
Gaudium IVF & Women Health IPO reservation details show category-wise allocation of shares. Out of the total 20886200 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 6265860 (30%) | |
| QIB Shares Offered | 4177240 (20%) | |
| NII (HNI) Shares Offered | 3132930 (15%) | |
| bHNI > ₹10L | 2088620 (10%) | 789 |
| sHNI < ₹10L | 1044310 (5%) | 395 |
| Retail Shares Offered | 7310170 (35%) | 38,678 |
| Total Shares Offered | 20886200 (100%) |
Gaudium IVF & Women Health IPO Analytics
Gaudium IVF & Women Health Valuations
Earnings
- EPS Pre IPO
- ₹3.12/-
- EPS Post IPO
- ₹3.44/-
- P/E Pre IPO
- 25.36
- P/E Post IPO
- 22.99
Returns
- ROE
- 41.31%
- ROCE
- 39.70%
- RoNW
- 41.71%
- PAT Margin
- 26.96%
Fundamentals
- Debt / Equity
- 0.41
- Price / Book
- 10.48
- Market Cap
- 575.02 Cr.
Gaudium IVF & Women Health Financials( In Crs.)
| 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Revenue | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| Net Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves & Surplus | 28.16 | 15.60 | 26.00 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Gaudium IVF & Women Health Company & Offer Insights
About Gaudium IVF & Women Health
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.
The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes. The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna; and Bangalore, covering all important locations across the subcontinent.
This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions.
These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.
Gaudium IVF & Women Health Promoter(s)
Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna are the company's promoters of Gaudium IVF & Women Health.
Gaudium IVF & Women Health IPO Issue Objectives
- •
- Funding capital expenditure towards establishment of New IVF Centers of the Company - ₹50 Cr.
- •
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company - ₹20 Cr.
- •
- General Corporate Purpose
Gaudium IVF & Women Health IPO - Anchor Investors
Gaudium IVF mobilises Rs 49.5 crore through anchor book for Rs 165-crore IPO.
Gaudium IVF has allocated 62.65 lakh shares to four anchor investors at the higher price band. Meru Investment Fund was the largest among the anchor investors, investing close to Rs 17 crore for 21.51 lakh shares, followed by Sanshi Fund, which invested 15.8 lakh shares worth Rs 12.5 crore.
Hornbill Orchid India Fund, and Carnelian India Multi-Strategy Fund invested 12.6 lakh shares worth Rs 10 crore each.
Gaudium IVF & Women Health IPO - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Revenue(in Cr.) | |
|---|---|---|---|---|
| Gaudium IVF | N/A | N/A | 41.71% | 70 |
| Progyny Inc. | 5.22 | 41.56 | 12.90% | 10128 |
| Inspire IVF | 0.25 | 11.43 | 3.97% | 26 |
Gaudium IVF & Women Health IPO - Strengths and Risks
Gaudium IVF & Women Health IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Gaudium IVF & Women Health
011-4885 8585
compliance@gaudiumivfcentre.com
https://www.gaudiumivfcentre.com/
B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Frequently Asked Questions
Click any question to reveal the answer
Gaudium IVF & Women Health IPO is a book-built IPO worth ₹165 crore. The price band is ₹75–₹79 per share. The IPO opens on Feb 20, 2026 and closes on Feb 24, 2026. It will be listed on BSE and NSE. Bigshare Services Pvt. Ltd. is the registrar.
The price band of Gaudium IVF & Women Health IPO is ₹75 to ₹79 per share.
The lot size of Gaudium IVF & Women Health IPO is 189 shares.
The minimum investment for Gaudium IVF & Women Health IPO is approximately ₹14,931 based on the upper price band .
Gaudium IVF & Women Health IPO opens on Feb 20, 2026 and closes on Feb 24, 2026.
The allotment date of Gaudium IVF & Women Health IPO is Feb 25, 2026.
Gaudium IVF & Women Health IPO is expected to be listed on Feb 27, 2026, on BSE and NSE .
The Grey Market Premium (GMP) for Gaudium IVF & Women Health IPO is ₹8-9 as of Feb 20, 2026. Based on the upper price band of ₹79, the estimated listing price is ₹87, representing a potential gain of approximately 10%.
Gaudium IVF & Women Health IPO valuation snapshot: P/E 22.99, EPS ₹3.44/-, P/B 10.48, RoNW 41.71%, and market cap 575.02 Cr.
To apply for Gaudium IVF & Women Health IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Gaudium IVF & Women Health IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Gaudium IVF & Women Health IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Gaudium IVF & Women Health IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gaudium IVF & Women Health IPO allotment status on IPO Ji for quick and easy access.